Conivaptan: a dual vasopressin receptor v1a/v2 antagonist [corrected].
about
Region-specific changes in transient receptor potential vanilloid channel expression in the vasopressin magnocellular system in hepatic cirrhosis-induced hyponatraemia.Vasopressin-receptor antagonists.Risk stratification and short-term prognosis in acute heart failure syndromes: a review of novel biomarkers.Conivaptan and its role in the treatment of hyponatremiaDevelopment and validation of an HPLC-MS/MS method for the determination of arginine-vasopressin receptor blocker conivaptan in human plasma and rat liver microsomes: application to a metabolic stability study.
P2860
Conivaptan: a dual vasopressin receptor v1a/v2 antagonist [corrected].
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Conivaptan: a dual vasopressin receptor v1a/v2 antagonist [corrected].
@en
type
label
Conivaptan: a dual vasopressin receptor v1a/v2 antagonist [corrected].
@en
prefLabel
Conivaptan: a dual vasopressin receptor v1a/v2 antagonist [corrected].
@en
P2093
P2860
P1476
Conivaptan: a dual vasopressin receptor v1a/v2 antagonist [corrected].
@en
P2093
Barbara Washington
Farhan Ali
Jalal K Ghali
M Adnan Raufi
P2860
P304
P356
10.1111/J.1527-3466.2007.00019.X
P577
2007-01-01T00:00:00Z